Join
Live feed
·
PRReleasevia Quantisnow
Cybin Inc. logo

Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024

ByQuantisnow·Wall Street's wire, on your screen.
CYBN· Cybin Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYBN (Cybin Inc.) and more on Quantisnow.